-
Mashup Score: 32A Letter to NIH and Dr. Anthony Fauci. Is Anybody Home? - 3 year(s) ago
Dr. David Chesler is knocking at the door of the mighty U.S. National Institutes of Health. He has something urgent to share. Dr. Chesler is a geriatric
Source: Trial Site NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0New Startup Formed to Use AI to Better Connect Patients to Clinical Trials via Websites - 3 year(s) ago
A novel website called Cancertrialsearch.com intelligently matches patients with gastrointestinal cancers to clinical trials based on seven (7) criteria
Source: Trial Site NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 557Columbia University-led Study Identifies Powerful Nasal Spray to Combat COVID-19 as Prophylaxis - 4 year(s) ago
With funding from both Columbia University Medical Center, New York, NY, and the National Institutes of Health (NIH), a multicenter, preclinical animal
Source: Trial Site NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0This Doctor has COVID. He has a plan. For all of us. - 4 year(s) ago
By Mary Beth Pfeiffer He is 57 years old with mild asthma, hypertension and atherosclerotic cardiovascular disease. His medical issues did not stop
Source: Trial Site NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1Medable Expands Leadership in Decentralized Trials to Drive Growth: The TrialSite Interview - 4 year(s) ago
TrialSite recently interviewed a group of new leaders at the white-hot, decentralized clinical trial venture called Medable. The Silicon Valley-based
Source: Trial Site NewsCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 59
By Mary Beth Pfeiffer The COVID-19 patient was in critical condition and declining quickly. “Speak to your mom now,” the pulmonologist recalled telling
Source: Trial Site NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 30Nitazoxanide (NT-300) Trial Comes to Northern Alabama as Cullman Clinical Trials Launches COVID-19 Targeting Study - 4 year(s) ago
Another antiparasitic drug has emerged as a potential treatment for COVID-19, and trial site organization in Cullman, Alabama, called Cullman Clinical
Source: Trial Site NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1Atlantic Health Research Leads Study Demonstrating the Potential of T Cell-based Vaccines Targeting COVID-19 - 4 year(s) ago
Atlantic Health System, a prominent New Jersey-based health system, took on enormous challenges during COVID-19 as its proximity to epicenter in New York
Source: Trial Site NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
By Joseph Constance The pharmaceutical industry has been quick to embrace virtual, or decentralized, clinical trials during the COVID-19 pandemic,
Source: Trial Site NewsCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 18How a Grass Roots Health Movement Led to Acceptance of Ivermectin as a COVID-19 Therapy in Peru - 4 year(s) ago
Perhaps Peru is the epicenter of the movement for off-label use of Ivermectin to treat COVID-19 patients. The doctors there swear by it. In fact, some of
Source: Trial Site NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
RT @Covid19Crusher: N. I. H. Nobody Is Home. https://t.co/LCKsoLTWTA